Update on scheme timetable RENERGEN LIMITED Incorporated in the Republic of South Africa (Registration number: 2014/195093/06) JSE Share code: REN A2X Share code: REN ISIN: ZAE000202610 LEI: 378900B1512179F35A69 Australian Business Number (ABN): 93 998 352 675 ASX Share code: RLT ("Renergen" or "the Company") UPDATE ON SCHEME TIMETABLE Renergen and ASP Isotopes Inc ("ASPI") wish to update shareholders on the progress being made in relation to the Scheme. Whilst not all regulatory approvals have yet been obtained, a key approval from the Competition Commission has paved the way for the two companies to plan integration processes and begin collaborating. "Both teams are excited at the prospect of closing out the remaining conditions precedent in the near future and formally combining the two businesses, and while the timetable is a little off schedule we certainly don't feel this is unusual when third party approvals are required for a large transaction. More importantly is the progress the two companies are making on the integration strategy given that the Competition Commission approval is now in place," said Renergen CEO Stefano Marani. SCHEME TIMETABLE Unless expressly defined otherwise, capitalised terms herein have the same meaning given to them in the combined circular distributed to Renergen Shareholders on 12 June 2025 ("Circular"). Renergen Shareholders are referred to the joint firm intention announcement released by Renergen and ASPI on 20 May 2025 and to the Circular, regarding the Offer made by ASPI to Renergen Shareholders to acquire all Renergen Shares. Renergen Shareholders are further referred to the announcements released by the Company on 10 July 2025, 23 July 2025 and 8 August 2025, regarding the fulfilment or waiver of the Scheme Conditions and various key Offer Conditions. As at the date of this announcement, the implementation of the Scheme remains subject to and will only become operative following the fulfilment (or, if applicable, waiver) of the outstanding Offer Conditions in paragraph 5.2.1 of the Circular, by 30 September 2025, unless such date is extended. The fulfilment of the outstanding Offer Conditions is well advanced and the Company and ASPI expect that they will be fulfilled in due course. The indicative dates and times relating to the implementation of the Scheme, as previously announced and set out in the Circular, anticipated that all Conditions would be fulfilled or waived, and that the compliance certificate would be received from the Takeover Panel, by 14 August 2025. Renergen Shareholders should note that, as the remaining Offer Conditions have not yet been fulfilled (or, where applicable, waived), the Scheme Finalisation Date has not yet occurred. Once it is in a position to do so, Renergen will announce the updated salient dates and times for the Scheme on SENS and on the ASX. INDEPENDENT BOARD RESPONSIBILITY STATEMENT The Independent Board of Renergen accepts responsibility for the information contained in this announcement and confirms that, to the best of its knowledge and belief, such information is true, and this announcement does not omit anything likely to affect the importance of such information. Johannesburg 14 August 2025 Transaction and Designated Advisor: PSG Capital Date: 14-08-2025 08:00:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.